Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.
The 2020 IOL Market Report provides an in-depth analysis of the 2020 intraocular lens market and future impact of the COVID-19 pandemic by country/region of the world. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. The analysis focuses on the 2020 market and forecasts market growth and evolution through 2025.
The “2020 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2020 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market.
On October 30, 2020, Market Scope invited 891 US ophthalmologists via our online survey portal to participate in part seven of a nine-part series of surveys to capture the impact of COVID-19 on ophthalmic practices. There were 117 participants, representing 33 states. This survey attracted a diverse group of doctors; 85 percent of respondents provide cataract surgery, 63 percent perform glaucoma surgery, 29 percent treat retina patients, and 31 percent provide cornea treatment. Most of these doctors offer multiple areas of treatment. All individual responses are kept strictly confidential, and we report only aggregate data.
Market Scope has been meticulously tracking the effects of COVID-19 on the ophthalmic industry since the onset. After surveying US practices throughout 2020, we recently began surveying in Europe to better understand the impact on patient backlog, surgical procedures, adoption of technology, patient selection, and much more more. Our "2021 European COVID-19 Ophthalmic Practice Impact Survey Report" summarizes those findings for industry and surgeons to gain valuable insight into the markets' recovery.
Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time. The OMP provides perspective on products, events, and market trends, and timely information and analysis on the following:
The 2021 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceuticals segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.
The 2021 Retinal Surgical Device Market Report provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2021 market and forecasts market growth and evolution through 2026.
The “2020 Ophthalmic Deals Book” analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
The report covers investments in ophthalmic ventures in 2020, with comparisons to 2018 and 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our US Retina Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.
Each update includes full-year forecasts, comparisons with prior years, and trend analysis.
The report offers a comprehensive analysis of the 2020 global market for surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.